Matesanz F - Search Results

1

Genome-wide significant association of ANKRD55 rs6859219 and multiple sclerosis risk.

Lill CM, Schjeide BM, Graetz C, Liu T, Damotte V, Akkad DA, Blaschke P, Gerdes LA, Kroner A, Luessi F, Cournu-Rebeix I, Hoffjan S, Winkelmann A, Touze E, Pico F, Corcia P, Otaegui D, Antigüedad A, Alcina A, Comabella M, Montalban X, Olascoaga J, Matesanz F, Dörner T, Li SC, Steinhagen-Thiessen E, Lindenberger U, Chan A, Rieckmann P, Hartung HP, Aktas O, Lohse P, Buttmann M, Kümpfel T, Kubisch C, Zettl UK, Epplen JT, Fontaine B, Zipp F, Vandenbroeck K, Bertram L. Lill CM, et al. Among authors: matesanz f. J Med Genet. 2013 Mar;50(3):140-3. doi: 10.1136/jmedgenet-2012-101411. Epub 2013 Jan 12. J Med Genet. 2013. PMID: 23315543 No abstract available.

2

Glutamine and tetrapeptide repeat variations affect the biological activity of different mouse interleukin-2 alleles.

Matesanz F, Alcina A. Matesanz F, et al. Eur J Immunol. 1996 Aug;26(8):1675-82. doi: 10.1002/eji.1830260802. Eur J Immunol. 1996. PMID: 8765005

We have recently described N-terminal differences in five IL-2 molecules from nine mouse strains analyzed (Matesanz, F., Alcina, A. and Pellicer, A., Immunogenetics 1993. 38: 300). ...

We have recently described N-terminal differences in five IL-2 molecules from nine mouse strains analyzed (Matesanz, F., Alcin …

3

High expression in bacteria and purification of polymorphic mouse interleukin 2 molecules.

Matesanz F, Alcina A. Matesanz F, et al. Cytokine. 1998 Apr;10(4):249-53. doi: 10.1006/cyto.1997.9998. Cytokine. 1998. PMID: 9617568

4

Induction of autoantibodies to different interleukin-2 allotypes.

Matesanz F, Alcina A. Matesanz F, et al. J Autoimmun. 1999 May;12(3):221-7. doi: 10.1006/jaut.1998.0274. J Autoimmun. 1999. PMID: 10222031

5

The -174/-597 promoter polymorphisms in the interleukin-6 gene are not associated with susceptibility to multiple sclerosis.

Fedetz M, Matesanz F, Pascual M, Martín J, Fernández O, Guerrero M, Alcina A. Fedetz M, et al. Among authors: matesanz f. J Neurol Sci. 2001 Sep 15;190(1-2):69-72. doi: 10.1016/s0022-510x(01)00595-0. J Neurol Sci. 2001. PMID: 11574109

6

Analysis of -631 and -475 interleukin-2 promoter single nucleotide polymorphisms in multiple sclerosis.

Fedetz M, Alcina A, Fernández O, Guerrero M, Delgado C, Matesanz F. Fedetz M, et al. Among authors: matesanz f. Eur J Immunogenet. 2002 Oct;29(5):389-90. doi: 10.1046/j.1365-2370.2002.00338.x. Eur J Immunogenet. 2002. PMID: 12358847

7

The Plasmodium falciparum fatty acyl-CoA synthetase family (PfACS) and differential stage-specific expression in infected erythrocytes.

Matesanz F, Téllez Md, Alcina A. Matesanz F, et al. Mol Biochem Parasitol. 2003 Jan;126(1):109-12. doi: 10.1016/s0166-6851(02)00242-6. Mol Biochem Parasitol. 2003. PMID: 12554091 No abstract available.

8

Lack of association between -384 and 114 IL-2 gene polymorphisms and rheumatoid arthritis.

Fedetz M, Matesanz F, Cáliz R, Ferrer MA, Collado MD, Alcina A, Martín J. Fedetz M, et al. Among authors: matesanz f. J Rheumatol. 2003 Mar;30(3):435-7. J Rheumatol. 2003. PMID: 12610796

9

Effects of the multiple sclerosis associated -330 promoter polymorphism in IL2 allelic expression.

Matesanz F, Fedetz M, Leyva L, Delgado C, Fernández O, Alcina A. Matesanz F, et al. J Neuroimmunol. 2004 Mar;148(1-2):212-7. doi: 10.1016/j.jneuroim.2003.12.001. J Neuroimmunol. 2004. PMID: 14975604

10

Protein tyrosine phosphatase gene (PTPN22) polymorphism in multiple sclerosis.

Matesanz F, Rueda B, Orozco G, Fernandez O, Leyva L, Alcina A, Martín J. Matesanz F, et al. J Neurol. 2005 Aug;252(8):994-5. doi: 10.1007/s00415-005-0795-y. Epub 2005 Mar 17. J Neurol. 2005. PMID: 15765267 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page